|
 |
 |
 |
 |
 |
 |
- Home
- Join or Change Subscription
- GSI Community
- For New Patients
- About GIST
- Pediatric GIST & Carney Triad
- Treatments
- Ask the Professional
- Learning Center
- Voices of GIST
- Educational Materials
- GIST Support Wiki
- Donate
XL147
 | |
 | |
XL147
This drug, an inhibitor of PI3K, is under preclinical development by Exelixis. It is expected to enter a Phase I trial late in 2007.
For information at the site of the manufacturer click here.
